113 related articles for article (PubMed ID: 7712123)
1. Synthesis, antiviral activity, and bioavailability studies of gamma-lactam derived HIV protease inhibitors.
Hungate RW; Chen JL; Starbuck KE; Vacca JP; McDaniel SL; Levin RB; Dorsey BD; Guare JP; Holloway MK; Whitter W
Bioorg Med Chem; 1994 Sep; 2(9):859-79. PubMed ID: 7712123
[TBL] [Abstract][Full Text] [Related]
2. HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent.
Duffy JL; Rano TA; Kevin NJ; Chapman KT; Schleif WA; Olsen DB; Stahlhut M; Rutkowski CA; Kuo LC; Jin L; Lin JH; Emini EA; Tata JR
Bioorg Med Chem Lett; 2003 Aug; 13(15):2569-72. PubMed ID: 12852968
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activity.
Hagen SE; Prasad JV; Boyer FE; Domagala JM; Ellsworth EL; Gajda C; Hamilton HW; Markoski LJ; Steinbaugh BA; Tait BD; Lunney EA; Tummino PJ; Ferguson D; Hupe D; Nouhan C; Gracheck SJ; Saunders JM; VanderRoest S
J Med Chem; 1997 Nov; 40(23):3707-11. PubMed ID: 9371233
[No Abstract] [Full Text] [Related]
5. Synthesis of amino acid derived seven-membered lactams by RCM and their evaluation against HIV protease.
Zaman S; Campaner P; Abell AD
Bioorg Med Chem; 2006 Dec; 14(24):8323-31. PubMed ID: 17010620
[TBL] [Abstract][Full Text] [Related]
6. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease.
Kaldor SW; Kalish VJ; Davies JF; Shetty BV; Fritz JE; Appelt K; Burgess JA; Campanale KM; Chirgadze NY; Clawson DK; Dressman BA; Hatch SD; Khalil DA; Kosa MB; Lubbehusen PP; Muesing MA; Patick AK; Reich SH; Su KS; Tatlock JH
J Med Chem; 1997 Nov; 40(24):3979-85. PubMed ID: 9397180
[TBL] [Abstract][Full Text] [Related]
7. Design of orally bioavailable, symmetry-based inhibitors of HIV protease.
Kempf DJ; Marsh KC; Fino LC; Bryant P; Craig-Kennard A; Sham HL; Zhao C; Vasavanonda S; Kohlbrenner WE; Wideburg NE
Bioorg Med Chem; 1994 Sep; 2(9):847-58. PubMed ID: 7712122
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.
Wu X; Ohrngren P; Joshi AA; Trejos A; Persson M; Arvela RK; Wallberg H; Vrang L; Rosenquist A; Samuelsson BB; Unge J; Larhed M
J Med Chem; 2012 Mar; 55(6):2724-36. PubMed ID: 22376008
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors.
De Lucca GV; Liang J; De Lucca I
J Med Chem; 1999 Jan; 42(1):135-52. PubMed ID: 9888839
[TBL] [Abstract][Full Text] [Related]
10. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
11. Applications of 3-aminolactams: design, synthesis, and biological evaluation of a library of potential dimerisation inhibitors of HIV1-protease.
Pinyol E; Frutos S; Grillo-Bosch D; Giralt E; Clotet B; Esté JA; Diez A
Org Biomol Chem; 2012 Jun; 10(22):4348-54. PubMed ID: 22546925
[TBL] [Abstract][Full Text] [Related]
12. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
Fässler A; Bold G; Capraro HG; Cozens R; Mestan J; Poncioni B; Rösel J; Tintelnot-Blomley M; Lang M
J Med Chem; 1996 Aug; 39(16):3203-16. PubMed ID: 8759643
[TBL] [Abstract][Full Text] [Related]
13. SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.
Billich A; Fricker G; Müller I; Donatsch P; Ettmayer P; Gstach H; Lehr P; Peichl P; Scholz D; Rosenwirth B
Antimicrob Agents Chemother; 1995 Jul; 39(7):1406-13. PubMed ID: 7492076
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibitors of the HIV-1 protease with good oral bioavailabilities.
Sham HL; Zhao C; Marsh KC; Betebenner DA; Lin S; McDonald E; Vasavanonda S; Wideburg N; Saldivar A; Robins T
Biochem Biophys Res Commun; 1995 Jun; 211(1):159-65. PubMed ID: 7779082
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
[TBL] [Abstract][Full Text] [Related]
16. L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor.
Dorsey BD; Levin RB; McDaniel SL; Vacca JP; Guare JP; Darke PL; Zugay JA; Emini EA; Schleif WA; Quintero JC
J Med Chem; 1994 Oct; 37(21):3443-51. PubMed ID: 7932573
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship of HIV-1 protease inhibitors containing AHPBA. Part III: Modification of P2 site.
Takashiro E; Watanabe T; Nitta T; Kasuya A; Miyamoto S; Ozawa Y; Yagi R; Nishigaki T; Shibayama T; Nakagawa A; Iwamoto A; Yabe Y
Bioorg Med Chem; 1998 May; 6(5):595-604. PubMed ID: 9629473
[TBL] [Abstract][Full Text] [Related]
18. Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.
Melnick M; Reich SH; Lewis KK; Mitchell LJ; Nguyen D; Trippe AJ; Dawson H; Davies JF; Appelt K; Wu BW; Musick L; Gehlhaar DK; Webber S; Shetty B; Kosa M; Kahil D; Andrada D
J Med Chem; 1996 Jul; 39(14):2795-811. PubMed ID: 8709110
[TBL] [Abstract][Full Text] [Related]
19. 2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors.
Beaulieu PL; Anderson PC; Cameron DR; Croteau G; Gorys V; Grand-Maître C; Lamarre D; Liard F; Paris W; Plamondon L; Soucy F; Thibeault D; Wernic D; Yoakim C; Pav S; Tong L
J Med Chem; 2000 Mar; 43(6):1094-108. PubMed ID: 10737742
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.
Nagarajan SR; De Crescenzo GA; Getman DP; Lu HF; Sikorski JA; Walker JL; McDonald JJ; Houseman KA; Kocan GP; Kishore N; Mehta PP; Funkes-Shippy CL; Blystone L
Bioorg Med Chem; 2003 Nov; 11(22):4769-77. PubMed ID: 14556792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
